A detailed history of Brookmont Capital Management transactions in Johnson & Johnson stock. As of the latest transaction made, Brookmont Capital Management holds 14,866 shares of JNJ stock, worth $2.38 Million. This represents 1.19% of its overall portfolio holdings.

Number of Shares
14,866
Previous 15,047 1.2%
Holding current value
$2.38 Million
Previous $2.38 Million 8.74%
% of portfolio
1.19%
Previous 1.25%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

SELL
$144.38 - $157.78 $26,132 - $28,558
-181 Reduced 1.2%
14,866 $2.17 Million
Q1 2024

Apr 16, 2024

BUY
$155.22 - $162.74 $30,267 - $31,734
195 Added 1.31%
15,047 $2.38 Million
Q4 2023

Jan 18, 2024

BUY
$145.6 - $158.88 $9,318 - $10,168
64 Added 0.43%
14,852 $2.33 Million
Q3 2023

Oct 12, 2023

SELL
$155.75 - $174.48 $13,238 - $14,830
-85 Reduced 0.57%
14,788 $2.3 Million
Q2 2023

Jul 13, 2023

SELL
$154.35 - $166.11 $1,080 - $1,162
-7 Reduced 0.05%
14,873 $2.46 Million
Q1 2023

Apr 11, 2023

BUY
$151.05 - $180.26 $4,531 - $5,407
30 Added 0.2%
14,880 $2.31 Million
Q4 2022

Feb 06, 2023

SELL
$160.2 - $179.79 $78,818 - $88,456
-492 Reduced 3.21%
14,850 $2.62 Million
Q3 2022

Oct 12, 2022

BUY
$161.33 - $179.52 $151,488 - $168,569
939 Added 6.52%
15,342 $2.51 Million
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $83,085 - $91,888
-494 Reduced 3.32%
14,403 $2.56 Million
Q1 2022

May 09, 2022

BUY
$158.14 - $179.59 $27,832 - $31,607
176 Added 1.2%
14,897 $2.64 Million
Q4 2021

Jan 27, 2022

SELL
$155.93 - $173.01 $95,117 - $105,536
-610 Reduced 3.98%
14,721 $2.52 Million
Q3 2021

Nov 15, 2021

BUY
$161.5 - $179.47 $15,988 - $17,767
99 Added 0.65%
15,331 $2.48 Million
Q2 2021

Jul 19, 2021

SELL
$159.48 - $171.07 $1,594 - $1,710
-10 Reduced 0.07%
15,232 $2.51 Million
Q1 2021

Apr 15, 2021

SELL
$153.07 - $170.48 $38,573 - $42,960
-252 Reduced 1.63%
15,242 $2.51 Million
Q4 2020

Feb 04, 2021

SELL
$137.11 - $157.38 $86,653 - $99,464
-632 Reduced 3.92%
15,494 $2.44 Million
Q3 2020

Oct 16, 2020

BUY
$140.38 - $153.83 $40,289 - $44,149
287 Added 1.81%
16,126 $2.4 Million
Q2 2020

Jul 23, 2020

SELL
$128.81 - $155.51 $522,324 - $630,593
-4,055 Reduced 20.38%
15,839 $2.23 Million
Q1 2020

Apr 28, 2020

SELL
$111.14 - $153.99 $85,800 - $118,880
-772 Reduced 3.74%
19,894 $2.61 Million
Q4 2019

Jan 22, 2020

SELL
$127.5 - $146.44 $224,017 - $257,295
-1,757 Reduced 7.84%
20,666 $3.02 Million
Q3 2019

Nov 07, 2019

SELL
$126.95 - $142.14 $22,470 - $25,158
-177 Reduced 0.78%
22,423 $2.9 Million
Q2 2019

Jul 18, 2019

BUY
$131.15 - $144.24 $19,016 - $20,914
145 Added 0.65%
22,600 $3.15 Million
Q1 2019

Apr 16, 2019

BUY
$125.72 - $139.79 $4,651 - $5,172
37 Added 0.17%
22,455 $3.14 Million
Q4 2018

Feb 12, 2019

BUY
$122.84 - $147.84 $140,160 - $168,685
1,141 Added 5.36%
22,418 $2.89 Million
Q3 2018

Nov 08, 2018

BUY
$121.58 - $142.88 $15,683 - $18,431
129 Added 0.61%
21,277 $2.94 Million
Q2 2018

Jul 19, 2018

BUY
$119.4 - $131.76 $31,999 - $35,311
268 Added 1.28%
21,148 $2.57 Million
Q1 2018

May 14, 2018

SELL
$125.1 - $148.14 $2.6 Million - $3.08 Million
-20,776 Reduced 49.88%
20,880 $2.68 Million
Q4 2017

Feb 12, 2018

BUY
$131.22 - $143.62 $1.75 Million - $1.91 Million
13,320 Added 47.01%
41,656 $5.82 Million
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $3.67 Million - $3.84 Million
28,336
28,336 $3.68 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $419B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Brookmont Capital Management Portfolio

Follow Brookmont Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookmont Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brookmont Capital Management with notifications on news.